Chk2 Inhibitor Chemical Properties

storage temp. 

-20C

solubility 

DMSO: Soluble

form 

Pale yellow solid

Chk2 Inhibitor Usage And Synthesis

Uses

Chk2 Inhibitor is a checkpoint kinase inhibitor that mediates apoptosis and cell cycle arrest.

General Description

A cell-permeable, ATP competitive, and reversible indoloazepine compound that displays anti-proliferative and anti-inflammatory properties. Acts as a potent inhibitor of Chk2 (IC₅₀ = 8 nM) that targets the ATP binding pocket. Exhibits selectivity for Chk2 over MEK1, Chk1, CK1δ, PKCα, PKCβII and CK2 (IC₅₀ = 89 nM, 237 nM, 1.352 μM, 2.539 μM, 3.381 μM, and >10.0 μM, respectively). Blocks the production of IL-2 and TNF-α by preventing the transcriptional activation of NF-κB (IC₅₀ = 3.55 μM for IL-2 production in PMA-stimulated Jurkat T cells; 8.16 μM for TNF-α production in LPS-stimulated THP-1 cells). Also reported to suppress the growth of leukemic T cells (GI₅₀ = 1.73 μM).

Biochem/physiol Actions

Primary TargetChk2

Chk2 Inhibitor(724708-21-8)Related Product Information

• 2-[(6-Amino-9H-purin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone
• N-[4-[5-(1,3-BENZODIOXOL-5-YL)-3-METHOXY-1H-1,2,4-TRIAZOL-1-YL]PHENYL]-2-(PHENYLTHIO)ACETAMIDE
• NSC 23766 TETRAHYDROCHLORIDE
• NSC697923
• MIF Antagonist, ISO-1
• GSK-3β Inhibitor XVIII
• Pictilisib
• JNJ-10198409
• Trolox
• C2 CERAMIDE
• Motesanib
• PD 173074
• Compound 28
• Glycogen Phosphorylase Inhibitor
• MMP-9 INHIBITOR I
• Compound 23
• ERK Inhibitor
• 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID